About our mycoplasma test
Genital mycoplasma disease is caused by the bacterium Mycoplasma genitalium (M genitalium), which since it was discovered in 1980 has become increasingly common in Sweden.
The more people who get tested, the greater the opportunity is to reduce the spread. For that many to test themselves, however, it must be both simple and secure. Therefore we have developed a mycoplasma test which is as safe as existing medical tests but easier for the patient to perform. Because chlamydia and mycoplasma produce similar symptoms we also offer a combined test which gives a quick answer on whether the sample is infected with mycoplasma and/or chlamydia.
We offer different cooperative opportunities in which we tailor solutions for each customer. Our concept covers the entire chain from sampling kits and method of analysis to performing analysis and distribution of analytical results. Examples of our collaborators include county councils and health centres. The test is also available for sale directly to consumers via our webshop.
As secure as existing medical tests
For our mycoplasma test the patient takes a simple sample at home and then sends it to our accredited (ISO/IEC 17025) and quality-assured laboratory for analysis. The CE-marked sampling kit contains sampling material, instructions and return packaging. Women take a vaginal sample and men take a urine sample. 24 days (weekdays) after the sample arrives at our laboratory the result can be accessed on our website with a personal code. We can also report the analysis results in other ways, such as through our partners own websites.
Patients who get a positive result and have mycoplasma will then be refered to medical care. This means that health care is freed from visits by people who do not have mycoplasma and the first to make contact are those who need care. Untreated mycoplasma can cause cervical, uterine and fallopian infections in women. Men can get urinary tract infections, epididymitis, and prostate problems. Patients who receive a negative response but still have symptoms are encouraged to take a new test as well as test for other sexually transmitted infections such as chlamydia, which has similar symptoms. We have both a separate test for chlamydia and a combination test where mycoplasma and chlamydia are analysed in the same sample.
Unique and safe method of analysis
The Dynamic Code method of analysis for detection of the bacteria M genitalium is based on PCR and includes two target sequences. Dynamic Code uses a methodology of analysis which covers any newly arising mutations in the bacterium. The analysis results have high certainty.
Information and price quotes
Order mycoplasma test
For more information about our mycoplasma test and potential collaboration, contact us.
Phone: +46(0)13 465 53 20
Quality and security
The Dynamic Code method for detecting M genitalium is based on PCR. In a validation study of 200 samples (19 positive and 181 negative) in which Dynamic Code’s method was compared with external laboratory results, 100% specificity and selectivity were demonstrated.
Analyses in the Dynamic Code laboratory are accredited under ISO/IEC 17025 and reviewed by the Swedish Board for Accreditation and Conformity Assessment (SWEDAC)
For external ongoing quality control Dynamic Code participates in external quality research in laboratory medicine in Sweden’s (EQUALIS) quality program DNA analysis.
Sampling kits are CE marked according to IVD Directive 98/79/EC as well as the MDD directive 93/42/EEC and in addition to future legislative changes.
Studies have shown that the method used is secure and instructions for the mycoplasma test are clear and safe when it comes to taking the sample correctly, sending the sample and obtaining the results. Overall, this creates certainty of 99.5 %.
The mycoplasma test is registered with the Swedish Food and Drug Administration.